Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials
Not yet recruiting
- Conditions
- Atopic Dermatitis
- Registration Number
- NCT06174493
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical trials, specifically focused on atopic dermatitis, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.
The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Ability to understand and the willingness to sign a written informed consent document
- Participant must be 18 years of age or older
- Confirmed diagnosis of atopic dermatitis
Exclusion Criteria
- Enrolled in another research study
- Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
- Inability to provide written informed consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of atopic dermatitis patients who decide to enroll in a clinical research 3 months Rate of atopic dermatitis patients who remain in clinical trial to trial completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States